Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Biganzoli · SciRah

Researcher profile · Semantic Scholar

L. Biganzoli

Share profile

L. Biganzoli — researcher profile on SciRah

h-index: 56
Works: 342
Citations: 14K

Most-cited papers

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F. Cardoso, S. Paluch-Shimon, E. Senkus, G. Curigliano +41 more
2020Annals of Oncology1,241 citations Open access
Semantic Scholar
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
F. Cardoso, E. Senkus, A. Costa, E. Papadopoulos +38 more
2018Annals of Oncology1,036 citations Open access
Semantic Scholar
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.
S. Loi, A. Giobbie-Hurder, A. Gombos, T. Bachelot +54 more
2019The Lancet Oncology412 citations
Semantic Scholar
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).
L. Biganzoli, N. Battisti, H. Wildiers, A. McCartney +14 more
2021The Lancet Oncology240 citations Open access
Semantic Scholar
Metal recovery from incineration bottom ash: State-of-the-art and recent developments.
M. Šyc, F. Simon, J. Hykš, Roberto Braga +4 more
2020Journal of Hazardous Materials174 citations Open access
Semantic Scholar
The requirements of a specialist breast centre
L. Biganzoli, F. Cardoso, Marc Beishon, D. Cameron +23 more
2020Breast142 citations Open access
Semantic Scholar
Metabolomics in breast cancer: A decade in review.
A. McCartney, A. Vignoli, L. Biganzoli, R. Love +3 more
2018Cancer Treatment Reviews101 citations
Semantic Scholar
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination With Fulvestrant in Patients With AKT1E17K-Mutant, ER-Positive Metastatic Breast Cancer
L. Smyth, K. Tamura, M. Oliveira, E. Ciruelos +24 more
2020Clinical Cancer Research91 citations Open access
Semantic Scholar
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
L. Goldstein, M. Mansutti, C. Lévy, Jenny C. Chang +49 more
2021Breast Cancer Research and Treatment77 citations Open access
Semantic Scholar
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology
F. Galardi, F. De Luca, Dario Romagnoli, C. Biagioni +6 more
2020Biomolecules66 citations Open access
Semantic Scholar
Natural and enhanced carbonation of lime in its different applications: a review
F. Campo, Camilla Tua, L. Biganzoli, S. Pantini +1 more
2021Environmental Technology Reviews59 citations Open access
Semantic Scholar
Life Cycle Assessment of Reusable Plastic Crates (RPCs)
Camilla Tua, L. Biganzoli, M. Grosso, L. Rigamonti
2019Resources56 citations Open access
Semantic Scholar
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
M. Garutti, G. Griguolo, A. Botticelli, Giulia Buzzatti +21 more
2022Cancers50 citations Open access
Semantic Scholar
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial
A. McCartney, M. Bonechi, F. De Luca, C. Biagioni +13 more
2020Clinical Cancer Research50 citations Open access
Semantic Scholar
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer.
I. Migliaccio, M. Bonechi, A. McCartney, C. Guarducci +4 more
2020Cancer Treatment Reviews44 citations
Semantic Scholar
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT).
A. McCartney, C. Biagioni, G. Schiavon, M. Bergqvist +15 more
2019European Journal of Cancer44 citations
Semantic Scholar
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer
I. Krop, V. Abramson, M. Colleoni, T. Traina +20 more
2020Clinical Cancer Research43 citations
Semantic Scholar
HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology.
E. Brain, P. Caillet, N. D. de Glas, L. Biganzoli +3 more
2019Journal of Geriatric Oncology43 citations Open access
Semantic Scholar
Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey.
I. T. Rubio, L. Wyld, A. Esgueva, Tibor Kovacs +8 more
2019European Journal of Surgical Oncology41 citations
Semantic Scholar
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
A. Vignoli, E. Risi, A. McCartney, I. Migliaccio +5 more
2021International Journal of Molecular Sciences36 citations Open access
Semantic Scholar
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial
F. Galardi, F. De Luca, C. Biagioni, I. Migliaccio +15 more
2021Breast Cancer Research33 citations Open access
Semantic Scholar
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
M. Cazzaniga, L. Biganzoli, L. Cortesi, S. De Placido +13 more
2019OncoTargets and Therapy33 citations Open access
Semantic Scholar
Packaging re-use: a starting point for its quantification
L. Rigamonti, L. Biganzoli, M. Grosso
201929 citations Open access
Semantic Scholar
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel
G. Bianchini, G. Arpino, L. Biganzoli, S. Lonardi +4 more
2022Cancers28 citations Open access
Semantic Scholar
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting
S. Di Donato, A. Vignoli, C. Biagioni, L. Malorni +16 more
2021Cancers24 citations Open access
Semantic Scholar
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
M. Dieci, L. Del Mastro, M. Cinquini, F. Montemurro +13 more
2019Cancers24 citations Open access
Semantic Scholar
The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review.
L. Rossi, A. McCartney, I. De Santo, E. Risi +4 more
2019Cancer Treatment Reviews20 citations
Semantic Scholar
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial
L. Rossi, C. Biagioni, A. McCartney, I. Migliaccio +16 more
2019Breast Cancer Research20 citations Open access
Semantic Scholar
LCA evaluation of packaging re-use: the steel drums case study
L. Biganzoli, L. Rigamonti, M. Grosso
2018Journal of Material Cycles and Waste Management19 citations
Semantic Scholar
Intermediate Bulk Containers Re-use in the Circular Economy: An LCA Evaluation
L. Biganzoli, L. Rigamonti, M. Grosso
201819 citations Open access
Semantic Scholar
The role of abemaciclib in treatment of advanced breast cancer
A. McCartney, E. Moretti, G. Sanna, M. Pestrin +4 more
2018Therapeutic Advances in Medical Oncology18 citations Open access
Semantic Scholar
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care.
F. Cardoso, A. McCartney, A. Ponti, L. Marotti +12 more
2023European Journal of Cancer17 citations Open access
Semantic Scholar
Multigene tests for breast cancer: the physician’s perspective
F. Cognetti, L. Biganzoli, S. De Placido, L. Del Mastro +8 more
2021OncoTarget17 citations Open access
Semantic Scholar
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
S. Leo, E. Arnoldi, L. Repetto, Z. Coccorullo +17 more
2019The Oncologist17 citations Open access
Semantic Scholar
Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
L. Rossi, A. McCartney, E. Risi, I. De Santo +4 more
2019Clinical Breast Cancer15 citations
Semantic Scholar
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
I. Migliaccio, Marta Paoli, E. Risi, C. Biagioni +3 more
2022npj Breast Cancer14 citations Open access
Semantic Scholar
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
A. McCartney, A. Vignoli, L. Tenori, M. Fornier +5 more
2019npj Breast Cancer14 citations Open access
Semantic Scholar
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).
S. Gori, F. Puglisi, M. Cinquini, G. Pappagallo +9 more
2018European Journal of Cancer13 citations Open access
Semantic Scholar
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
F. Miglietta, M. Cinquini, M. Dieci, L. Cortesi +14 more
2022Breast12 citations Open access
Semantic Scholar
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer
L. Biganzoli, S. Cinieri, R. Berardi, R. Pedersini +22 more
2020Breast Cancer Research12 citations Open access
Semantic Scholar
A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments
F. Cardoso, N. Wilking, R. Bernardini, L. Biganzoli +8 more
2020Breast12 citations Open access
Semantic Scholar
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic review
N. Battisti, N. D. de Glas, E. Soto-Pérez-de-Celis, G. Liposits +10 more
2022European Journal of Cancer11 citations Open access
Semantic Scholar
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer
I. Migliaccio, Angela Leo, F. Galardi, C. Guarducci +5 more
2021Cancers11 citations Open access
Semantic Scholar
Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience
A. Losurdo, A. Lisa, M. Tomatis, A. Ponti +25 more
2022Breast Cancer Research and Treatment10 citations Open access
Semantic Scholar
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
P. V. van Dam, M. Tomatis, A. Ponti, L. Marotti +52 more
2022European Journal of Cancer10 citations Open access
Semantic Scholar
The Conundrum of the Association of Chemotherapy With Survival Outcomes Among Elderly Patients With Curable Luminal Breast Cancer.
N. M. L. Battisti, A. McCartney, L. Biganzoli
2020JAMA Oncology10 citations
Semantic Scholar
European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes
L. Biganzoli, L. Marotti, M. Cardoso, L. Cataliotti +8 more
2019Breast Care9 citations Open access
Semantic Scholar
Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen receptor & HER2 positive (ER+/HER2+) breast cancer (BC) (International Breast Cancer Study Group IBCSG 55-17, TOUCH)
L. Biganzoli, E. Brain, L. Malorni, E. Risi +1 more
2019Annals of Oncology8 citations Open access
Semantic Scholar
Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature
L. Rossi, C. Biagioni, A. McCartney, E. Moretti +6 more
2018Anticancer Research8 citations Open access
Semantic Scholar
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.
A. Frassoldati, L. Biganzoli, R. Bordonaro, S. Cinieri +12 more
2019Future Oncology7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. McCartney×17
Invite
A. McCartney — researcher profile on SciRah
A. Di Leo×15
Invite
A. Di Leo — researcher profile on SciRah
L. Malorni×15
Invite
L. Malorni — researcher profile on SciRah
E. Risi×12
Invite
E. Risi — researcher profile on SciRah

×11

Invite

I. Migliaccio — researcher profile on SciRah

Invite

C. Biagioni — researcher profile on SciRah

Invite

E. Moretti — researcher profile on SciRah

Invite

M. Benelli — researcher profile on SciRah

G. Curigliano×6

Invite

G. Curigliano — researcher profile on SciRah

Invite

L. Marotti — researcher profile on SciRah

Invite

M. Grosso — researcher profile on SciRah

L. Del Mastro×6

Invite

L. Del Mastro — researcher profile on SciRah